Sera Prognostics company info

What does Sera Prognostics do?
Sera Prognostics (NASDAQ:SERA), a biotech firm based in the United States, focuses on improving maternal and neonatal health through innovative blood tests. The company's primary project, the PreTRM test, aims to predict the risk of preterm birth, enabling earlier interventions and potentially better outcomes for mothers and babies. Sera Prognostics is committed to expanding its research and product line to address a wide range of pregnancy-related complications, striving to become a key player in prenatal care by leveraging cutting-edge technology and scientific findings.
Sera Prognostics company media
Company Snapshot

Is Sera Prognostics a public or private company?

key
Ownership
Public

How many people does Sera Prognostics employ?

people
Employees
56

What sector is Sera Prognostics in?

pie chart
Sector
Health Care

Where is the head office for Sera Prognostics?

location pin
Head Office
Salt Lake City, United States

What year was Sera Prognostics founded?

founded flag
Year Founded
2008
What does Sera Prognostics specialise in?
/Preterm Birth Test /Prenatal Diagnostics /PreTRM Test /Risk Evaluation /Clinical Research /Biotechnology Solutions

What are the products and/or services of Sera Prognostics?

Overview of Sera Prognostics offerings
PreTRM Test, a blood test that predicts the risk of preterm birth in pregnant women.
Strategic partnership with Anthem, Inc. to investigate the economic benefits of improving outcomes in pregnancies through early prediction.
Development of innovative diagnostic tests targeting pregnancy complications, aiming to transform prenatal care.
Provision of comprehensive testing services to healthcare providers for better management of high-risk pregnancies.
Utilization of cutting-edge proteomics technology to advance maternal and fetal health research.

Who is in the executive team of Sera Prognostics?

Sera Prognostics leadership team
  • Ms. Evguenia  Lindgardt M.B.A.
    Ms. Evguenia Lindgardt M.B.A.
    President, CEO & Director
  • Dr. Gregory C. Critchfield M.D., M.S.
    Dr. Gregory C. Critchfield M.D., M.S.
    Executive Director
  • Dr. Steven W. Graves
    Dr. Steven W. Graves
    Co-Founder and Co-Chairman of The Scientific Advisory Board
  • Dr. M. Sean Esplin M.D.
    Dr. M. Sean Esplin M.D.
    Co-Founder and Co-Chairman of Scientific Advisory Board
  • Mr. Austin  Aerts
    Mr. Austin Aerts
    Chief Financial Officer??
  • Dr. John J. Boniface Ph.D.
    Dr. John J. Boniface Ph.D.
    Chief Scientific Officer
  • Mr. Robert G. Harrison
    Mr. Robert G. Harrison
    Chief Information Officer
  • Mr. Benjamin G. Jackson J.D.
    Mr. Benjamin G. Jackson J.D.
    General Counsel